Senior Manager, Financial Controls
- Employer
- OXB
- Location
- Oxford
- Salary
- Competitive
- Start date
- 1 Oct 2024
- Closing date
- 31 Oct 2024
View moreView less
- Discipline
- Finance / Administration, Finance, R & D , Biotechnology
- Hours
- Full Time
- Contract Type
- Permanent
- Experience Level
- Experienced (non-manager)
Job Details
Job description:
We pride ourselves on our integrity. We do what’s right for our employees, patients, and partners, and so can you.
We are seeking to recruit a Senior Manager, Financial Controls to drive the financial control framework across our global business (UK, France & US) inclusive of documentation, policies, procedures, process flows and risk registers. They will be both the driver and gatekeeper of our best practice financial control environment on our journey to operating as a large international corporate,
Our Finance team provide financial reporting, control, and accountancy across the OXB Businesses.
Your responsibilities in this role would be:
- The design and continual monitoring of the Group’s financial control framework ensuring ICFR Compliance across our global locations (UK, US and France) to ensure key controls are resilient, proportionate and effective.
- Ensure proportionate oversight in second-, and first-line financial controls are in place across
- Accurate reporting on the control’s environment to the CFO/GFC & Audit Committee.
- Ensuring the ongoing review and continuous improvement and of processes and controls across the Group.
- Leading the investigation, review and recommendations following a material error, omissions of evidence or lack of oversight with regards to key financial controls across the Group
- Liaise with appropriate stakeholders to ensure the Board is in a position to make the required risk and internal controls declarations.
- Liaise with external auditors to assist their understanding of the ICFR ahead of the annual and interim audit process and work with the to ensure appropriate documentation in place to allow timely closure between visits.
- The co-ordination of risk management forums across OXB.
- Ownership of the Audit Committee Report and principal risk sections of the Annual Report.
We are looking for:
- Educated to Degree level in Finance or Science, or hold the equivalent level of work experience
- Qualified to CA, ACCA or ACA or equivalent
- Experience working in a professional services firm with hands on experience of challenging processes and controls environments.
- Demonstratable experience in SOX & COSO frameworks.
- Detailed knowledge and understanding of financial controls, IT general controls & data interrogation techniques.
- Demonstrable experience in deploying and designing risk based, commercially proportionate financial controls.
- The ability to understanding the financial reporting and processes in a complex business environment.
- Good knowledge and ability to stay current on new technical literature and emerging best practice applicable to the internal control process from whichever source (e.g., FCA, FRC, IIA, PCAOB, SEC, etc.).
- Good knowledge of ERP systems processes and transactions.
- A strong influencer and communicator with the ability to build relationships and work cross functionally.
About Us:
Oxford Biomedica is a quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organization) with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus, and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
- Highly total reward packages
- Wellbeing programmes
- Development opportunities
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Deliver Innovation, Be Inspiring and Have Integrity
- State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
Collaborate. Contribute. Change lives
Profile description:
We are looking for:
- Educated to Degree level in Finance or Science, or hold the equivalent level of work experience
- Qualified to CA, ACCA or ACA or equivalent
- Experience working in a professional services firm with hands on experience of challenging processes and controls environments.
- Demonstratable experience in SOX & COSO frameworks.
- Detailed knowledge and understanding of financial controls, IT general controls & data interrogation techniques.
- Demonstrable experience in deploying and designing risk based, commercially proportionate financial controls.
- The ability to understanding the financial reporting and processes in a complex business environment.
- Good knowledge and ability to stay current on new technical literature and emerging best practice applicable to the internal control process from whichever source (e.g., FCA, FRC, IIA, PCAOB, SEC, etc.).
- Good knowledge of ERP systems processes and transactions.
- A strong influencer and communicator with the ability to build relationships and work cross functionally.
About Us:
Oxford Biomedica is a quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organization) with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus, and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
- Highly total reward packages
- Wellbeing programmes
- Development opportunities
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Deliver Innovation, Be Inspiring and Have Integrity
- State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
Collaborate. Contribute. Change lives
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
Company
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
- Highly competitive total reward packages
- Wellbeing programmes Development opportunities
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Responsible, Responsive, Resilient, Respect
- State of the art laboratory and manufacturing facilities
- Website
- http://www.oxb.com/
- Telephone
- +44 (0) 1865 783 000
- Location
-
Windrush Court, Transport Way
Oxford
Oxfordshire
OX4 6LT
United Kingdom
Get job alerts
Create a job alert and receive personalised job recommendations straight to your inbox.
Create alert